Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Avid Bioservices
(NASDAQ:CDMO)
Intraday
$7.05
-0.27
[-3.69%]
After-Hours
$7.05
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$7.05
-0.27
[-3.69%]
At close: Apr 26
$7.05
0
[0.00%]
After Hours: 7:30PM EDT
Get Report
Watch
Q3 2024 Earnings were released on Wed Apr 24th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Avid Bioservices Stock (NASDAQ:CDMO)
Avid Bioservices Stock (NASDAQ: CDMO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Avid Bioservices Maintains FY24 Revenue Guidance Of $137M-$147M, Est $138.656M
Benzinga Newsdesk
-
3 days ago
Avid Bioservices Q3 2024 GAAP EPS $(0.09) Misses $(0.05) Estimate, Sales $33.800M Beat $33.452M Estimate
Benzinga Newsdesk
-
3 days ago
Wednesday, March 20, 2024
Avid Bioservices Received A Notice From The Listing Qualifications Department Of Nasdaq Stock Market For Non Compliance With Listing Requirements As A Result Of Its Failure To File Its Quarterly Report On Form 10Q
Benzinga Newsdesk
-
Mar 20, 2024, 7:15AM
Monday, March 11, 2024
Stephens & Co. Maintains Overweight on Avid Bioservices, Lowers Price Target to $12
Benzinga Newsdesk
-
Mar 11, 2024, 11:00AM
Friday, March 08, 2024
9 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Mar 8, 2024, 12:35PM
Thursday, March 07, 2024
S&P 500 Gains 1%; Kroger Earnings Top Views
Avi Kapoor
-
Mar 7, 2024, 2:31PM
Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance
Vandana Singh
-
Mar 7, 2024, 1:40PM
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Mar 7, 2024, 1:35PM
Dow Gains 100 Points; Victoria's Secret Shares Plunge
Avi Kapoor
-
Mar 7, 2024, 12:35PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Mar 7, 2024, 12:31PM
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales
Avi Kapoor
-
Mar 7, 2024, 9:54AM
RBC Capital Reiterates Outperform on Avid Bioservices, Maintains $7 Price Target
Benzinga Newsdesk
-
Mar 7, 2024, 8:52AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Mar 7, 2024, 8:06AM
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 7, 2024, 8:05AM
Avid Bioservices shares are trading lower after the company reported certain preliminary Q3 financial results and announced a proposed $160 million private placement of convertible notes.
Benzinga Newsdesk
-
Mar 7, 2024, 7:10AM
Victoria's Secret Posts Weak Sales, Joins ADT, Avid Bioservices And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
-
Mar 7, 2024, 4:50AM
Avid Bioservices Prices Private Placement Of $160M 7.00% Convertible Senior Notes Due 2029
Benzinga Newsdesk
-
Mar 7, 2024, 2:50AM
Wednesday, March 06, 2024
Avid Bioservices shares are trading lower after the company reported certain preliminary Q3 financial results and announced a proposed $160 million private placement of convertible notes.
Benzinga Newsdesk
-
Mar 6, 2024, 5:00PM
Avid Bioservices Announces Proposed $160M Private Placement Of Convertible Notes Due 2029
Benzinga Newsdesk
-
Mar 6, 2024, 4:58PM
Avid Bioservices Announces Certain Preliminary Q3 Results, Sees Revenue $33.8M Vs $34.19M Est.; Maintaining Revenue Guidance For FY24 Of $137M-$147M Vs $138.9M Est.
Happy Mohamed
-
Mar 6, 2024, 4:52PM
Friday, January 26, 2024
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Jan 26, 2024, 10:30AM
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 15, 2024, 4:30PM
Thursday, January 11, 2024
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
Avi Kapoor
-
Jan 11, 2024, 6:40AM
Friday, December 08, 2023
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 8, 2023, 12:57PM
RBC Capital Maintains Outperform on Avid Bioservices, Lowers Price Target to $7
Benzinga Newsdesk
-
Dec 8, 2023, 12:36PM
Craig-Hallum Maintains Buy on Avid Bioservices, Lowers Price Target to $16
Benzinga Newsdesk
-
Dec 8, 2023, 12:11PM
Avid Bioservices shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered FY24 revenue guidance below estimates.
Benzinga Newsdesk
-
Dec 8, 2023, 8:59AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 8, 2023, 8:07AM
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 8, 2023, 8:05AM
Pharma Contract Service Provider Avid Bioservices Reports Negative Gross Margin In Q3, Issues Meek Outlook
Vandana Singh
-
Dec 8, 2023, 7:19AM
RH Posts Q3 Loss, Joins HashiCorp, Lululemon And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
-
Dec 8, 2023, 5:27AM
Keybanc Maintains Overweight on Avid Bioservices, Lowers Price Target to $14
Benzinga Newsdesk
-
Dec 8, 2023, 4:22AM
Thursday, December 07, 2023
Avid Bioservices Is Adjusting Revenue Guidance For FY24 From $145M-$165M To $137M-$147M Vs $154.09M Est.
Benzinga Newsdesk
-
Dec 7, 2023, 4:40PM
Avid Bioservices Q2 Adj $(0.12) Misses $(0.06) Estimate, Sales $25.39M Miss $33.21M Estimate
Benzinga Newsdesk
-
Dec 7, 2023, 4:36PM
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 7, 2023, 4:31PM
Earnings Scheduled For December 7, 2023
Benzinga Insights
-
Dec 7, 2023, 5:27AM
Wednesday, December 06, 2023
Avid Bioservices Earnings Preview
Benzinga Insights
-
Dec 6, 2023, 11:00AM
Monday, December 04, 2023
Alaska Air, Orthofix Medical And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Lisa Levin
-
Dec 4, 2023, 5:20AM
Wednesday, November 08, 2023
Avid Bioservices Partners With California Institute For Regenerative Medicine To Provide CDMO Services For Cell And Gene Therapy Programs
Benzinga Newsdesk
-
Nov 8, 2023, 8:09AM
Thursday, September 28, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Benzinga Insights
-
Sep 28, 2023, 11:00AM
William Blair Initiates Coverage On Avid Bioservices with Market Perform Rating
Benzinga Newsdesk
-
Sep 28, 2023, 10:20AM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 8, 2023, 1:58PM
RBC Capital Maintains Outperform on Avid Bioservices, Lowers Price Target to $15
Benzinga Newsdesk
-
Sep 8, 2023, 8:55AM
Thursday, September 07, 2023
Avid Bioservices Q1 EPS $(0.03), Inline, Sales $37.70M Beat $36.09M Estimate
Bill Haddad
-
Sep 7, 2023, 4:10PM
Earnings Scheduled For September 7, 2023
Benzinga Insights
-
Sep 7, 2023, 6:25AM
Wednesday, September 06, 2023
Earnings Outlook For Avid Bioservices
Benzinga Insights
-
Sep 6, 2023, 11:01AM
Thursday, June 22, 2023
Avid Bioservice's FY24 Shortfall Anticipated: Analyst Says Later Stage Backlog May Pay In Longer Run
Vandana Singh
-
Jun 22, 2023, 3:15PM
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
Lisa Levin
-
Jun 22, 2023, 2:55PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch